Detalhe da pesquisa
1.
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26).
Gynecol Oncol
; 167(3): 436-443, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220670
2.
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer.
Gynecol Oncol
; 164(3): 505-513, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063281
3.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 267-276, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539744
4.
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Breast Cancer Res Treat
; 181(1): 61-68, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200486
5.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048043
6.
Incidence of primary spontaneous pneumothorax is not associated with microclimatic variations. Results of a seven-year survey in a temperate climate area.
Monaldi Arch Chest Dis
; 87(1): 793, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28635192
7.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 15(4): 396-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582486
8.
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial.
Eur J Cancer
; 206: 114127, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797038
9.
Impact of 2 years of COVID-19 pandemic on ovarian cancer treatment in IRCCS-AUSL of Reggio Emilia.
Int J Gynaecol Obstet
; 163(2): 679-688, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358270
10.
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study.
Diagnostics (Basel)
; 11(3)2021 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33801055
11.
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.
Sci Rep
; 10(1): 18190, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097745
12.
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).
Target Oncol
; 13(4): 469-479, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948780
13.
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
J Clin Oncol
; 35(29): 3347-3353, 2017 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28825853
14.
Therapeutic activity of testosterone in metastatic breast cancer.
Anticancer Res
; 34(3): 1287-90, 2014 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24596374
15.
P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.
Am J Clin Oncol
; 26(6): 535-42, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14663368